VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | TERIKIDS study: teriflunomide in pediatric patients with relapsing MS

Tanuja Chitnis • 24 May 2020
EAN 2020
Multiple Sclerosis and Related Disorders Teriflunomide
TERIKIDS Treatment Trial Updates

Tanuja Chitnis, MD, FAAN, Massachusetts General Hospital, Boston, MA, discusses the TERIKIDS trial (NCT02201108) looking at the efficacy and safety of teriflunomide in pediatric patients with relapsing forms of multiple sclerosis (MS). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Tanuja Chitnis

1:45
MS disease stage modulates the relationship between serum neurofilament light and age
Tanuja Chitnis • 23 Feb 2021
1:34
Serum neurofilament levels are associated with health outcomes and resource use in MS
Tanuja Chitnis • 23 Feb 2021
1:13
The impact of the gut microbiota on clinical features in progressive MS
Tanuja Chitnis • 26 Apr 2021
1:08
Pediatric MS: where does research need to move?
Tanuja Chitnis • 24 May 2020

Related Videos

2:29
MS therapies: limited direct effect in CNS pathology
Augusto A. Miravalle • 5 May 2023
3:14
sGFAP as a biomarker in NMOSD
Friedemann Paul • 27 Apr 2023
2:02
Occurrence of PIRA in RRMS: current understanding
João José Cerqueira • 27 Apr 2023
1:46
Proposed criteria for the diagnosis of MOGAD
Friedemann Paul • 27 Apr 2023
The content of VJNeurology is intended for healthcare professionals